Please find enclosed voting results
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivo Bio Tech Ltd has disclosed the voting results of a Postal Ballot (not an AGM/EGM) conducted to seek shareholder approval for increasing the Authorised Share Capital and amending the Capital Clause of the Memorandum of Association. The last date for e-voting was August 2, 2025. Of the 1,98,93,889 total outstanding shares, 62,61,107 shares (31.47%) were voted, with 62,49,397 votes (99.81%) in favour and only 11,710 votes (0.19%) against the resolution. Promoters voted 100% in favour on 53,45,000 shares, while public non-institutions voted 98.72% in favour. The resolution was passed with the requisite majority, and no invalid votes were recorded.
The increase in authorised share capital gives the company flexibility to issue new shares in the future, potentially for fundraising, expansion, or stock splits/bonus issues, though no specific plan has been announced yet. The overwhelming shareholder approval (99.81%) signals broad consensus, but the actual dilution risk will depend on how and when the company utilises the expanded capital.